Protein kinase inhibitors for the treatment of inflammatory disease.
Player
Mark R
MR
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007154:Immune System Diseases / Q000473:pathology*; D007249:Inflammation / Q000473:pathology*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D047428:Protein Kinase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D048051:p38 Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors
D000893:Anti-Inflammatory Agents; D047428:Protein Kinase Inhibitors; D011493:Protein Kinase C; D048051:p38 Mitogen-Activated Protein Kinases